000111703 001__ 111703
000111703 005__ 20221124103219.0
000111703 0247_ $$2doi$$a10.3390/nursrep11020036
000111703 0248_ $$2sideral$$a127198
000111703 037__ $$aART-2021-127198
000111703 041__ $$aeng
000111703 100__ $$0(orcid)0000-0001-9971-2208$$aJorge-Samitier, P.$$uUniversidad de Zaragoza
000111703 245__ $$aManagement of Hypnotics in Patients with Insomnia and Heart Failure during Hospitalization: A Systematic Review
000111703 260__ $$c2021
000111703 5060_ $$aAccess copy available to the general public$$fUnrestricted
000111703 5203_ $$aBackground: Heart failure is a chronic, progressive syndrome of signs and symptoms, which has been associated to a range of comorbidities including insomnia. Acute decompensation of heart failure frequently leads to hospital admission. During hospital admission, long-term pharmacological treatments such as hypnotics can be modified or stopped. Aim: To synthesize the scientific evidence available about the effect of withdrawing hypnotic drugs during hospital admission in patients with decompensated heart failure and insomnia. Method: A systematic review of the literature following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines was carried out in the following scientific databases: PubMed, Scopus, Dialnet and Cochrane. Inclusion criteria: studies including a population of adults with heart failure and sleep disorders in treatment with hypnotics and admitted to hospital, studies written in English or Spanish and published until June 2020. Exclusion criteria: studies involving children, patients admitted to intensive care and patients diagnosed with sleep apnea. Results: We identified a total of 265 documents; only nine papers met the selection criteria. The most frequently used drugs for the treatment of insomnia in patients with heart failure were benzodiazepines and benzodiazepine agonists; their secondary effects can alter perceived quality of life and increase the risk of adverse effects. Withdrawal of these drugs during hospital admission could increase the risk of delirium. Future research in this area should evaluate the management of hypnotics during hospital admission in patients with decompensated heart failure. In addition, safe and efficient non-pharmacological alternatives for the treatment of insomnia in this population should be tested and implemented.
000111703 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000111703 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000111703 700__ $$0(orcid)0000-0002-6455-119X$$aFernandez-Rodrigo, M.T.$$uUniversidad de Zaragoza
000111703 700__ $$aJuarez-Vela, R.
000111703 700__ $$0(orcid)0000-0002-8206-4803$$aAnton-Solanas, I.$$uUniversidad de Zaragoza
000111703 700__ $$aGea-Caballero, V.
000111703 7102_ $$11006$$2255$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Enfermería
000111703 773__ $$g11, 2 (2021), 373-381$$pNurs. reports$$tNursing Reports$$x2039-439X
000111703 8564_ $$s619791$$uhttps://zaguan.unizar.es/record/111703/files/texto_completo.pdf$$yVersión publicada
000111703 8564_ $$s2758071$$uhttps://zaguan.unizar.es/record/111703/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000111703 909CO $$ooai:zaguan.unizar.es:111703$$particulos$$pdriver
000111703 951__ $$a2022-11-24-10:10:32
000111703 980__ $$aARTICLE